Depression symptoms of African American patients with cancer under-recognized
the ONA take:
Depression symptoms of African American patients with cancer are often under-recognized, a new study by researchers at Case Western Reserve University in Cleveland, Ohio, has found.
For the study, researchers sought to investigate whether depression in African American patients with cancer goes under-recognized for treatment.
The researchers identified 34 depressed African American cancer patients, 23 non-depressed African American cancer patients, and 17 depressed Caucasian cancer patients at a Northeast Ohio medical center.
All participants had been diagnosed with early-stage breast or prostate cancer within the last 3 years and received their last treatment at least 6 months ago. Patients were asked open-ended questions to assess their depression.
Results showed that depressed African American patients reported more irritability, wanting to be alone, insomnia, fatigue, and crying than non-depressed black patients.
Researchers also found that depressed black patients reported sad feelings less frequently than depressed white patients. Black patients were also more likely to use words like "feeling down," "low," "gloomy," or "blue" to describe their feeling rather than "depressed."
Depression symptoms of African American patients with cancer are often under-recognized.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|